Gyre Therapeutics, Inc.
GYRE
$6.68
$0.142.14%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 50.17% | -4.99% | -12.70% | 10.46% | 81.88% |
| Total Receivables | 5.36% | -27.43% | 37.86% | 5.69% | 12.61% |
| Inventory | 0.67% | 11.61% | 14.87% | -0.08% | 12.48% |
| Prepaid Expenses | 102.05% | 181.17% | -53.43% | 6.37% | -66.90% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 33.07% | -10.39% | 3.85% | 7.99% | 33.36% |
|
|
|||||
| Total Current Assets | 33.07% | -10.39% | 3.85% | 7.99% | 33.36% |
| Net Property, Plant & Equipment | 29.66% | -4.68% | -0.71% | 0.03% | -0.86% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -2.20% | -24.79% | 26.92% | -2.32% | -2.38% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.08% | 41.21% | -27.67% | 7.68% | 2.01% |
| Total Assets | 22.99% | -2.48% | 4.23% | 4.41% | 17.61% |
|
|
|||||
| Total Accounts Payable | 366.42% | 113.71% | -77.70% | 683.10% | -41.80% |
| Total Accrued Expenses | 20.93% | 10.02% | 27.76% | -25.70% | 32.91% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 84.42% | 18.08% | 1.60% | 0.64% | -22.73% |
| Total Finance Division Other Current Liabilities | 81.97% | 0.64% | 3.21% | 50.83% | -58.82% |
| Total Other Current Liabilities | 81.97% | 0.64% | 3.21% | 50.83% | -58.82% |
| Total Current Liabilities | 44.85% | 8.21% | 14.91% | -5.95% | -10.91% |
|
|
|||||
| Total Current Liabilities | 44.85% | 8.21% | 14.91% | -5.95% | -10.91% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2,723.61% | -76.24% | -43.78% | -30.09% | -1.15% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -29.59% | -1.73% | -4.64% | 0.09% | -3.59% |
| Total Liabilities | 37.18% | 4.95% | 8.56% | -5.32% | -8.97% |
|
|
|||||
| Common Stock & APIC | 37.77% | 1.51% | 2.94% | 3.53% | 16.82% |
| Retained Earnings | -81.46% | -13.30% | -2.71% | 5.37% | 0.65% |
| Treasury Stock & Other | 154.61% | 175.22% | 54.18% | 25.67% | 8.00% |
| Total Common Equity | 6.53% | -4.45% | 4.03% | 10.75% | 35.09% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.53% | -4.45% | 4.03% | 10.75% | 35.09% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -3.13% | -1.59% | 2.13% | -5.14% | 3.42% |
| Total Equity | 20.39% | -3.72% | 3.54% | 6.16% | 24.10% |
|
|
|||||